Fortrea
Phil Williams is a seasoned professional in strategic partnerships and business development with extensive experience in the clinical research and pharmaceutical industries. Currently serving as Senior Director of Strategic Partnerships at Fortrea since June 2023, Phil previously held roles at Covance as Senior Director of Strategic Accounts from 2019 to June 2023 and as Director of Business Development from February 2002 to January 2003. Additional positions include Executive Director of Global Accounts at ICON plc for a brief period in 2018 and various roles at PPD between 2003 and 2018, culminating as Executive Account Director. Phil began a career at ICON Clinical Research as an Account Manager from 1997 to 2002. Phil holds a degree from Truman State University, completed between 1984 and 1989.
This person is not in any teams
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.